628 related articles for article (PubMed ID: 32295903)
1. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
2. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
[TBL] [Abstract][Full Text] [Related]
3. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
4. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
[TBL] [Abstract][Full Text] [Related]
5. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants.
Sede MM; Moretti FA; Laufer NL; Jones LR; Quarleri JF
PLoS One; 2014; 9(7):e102857. PubMed ID: 25032817
[TBL] [Abstract][Full Text] [Related]
7. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal ultradeep characterization of HIV type 1 R5 and X4 subpopulations in patients followed from primary infection to coreceptor switch.
Hedskog C; Brodin J; Heddini A; Bratt G; Albert J; Mild M
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1237-44. PubMed ID: 23745959
[TBL] [Abstract][Full Text] [Related]
9. Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.
Meehan CJ; Hedge JA; Robertson DL; McCormack GP; Travers SA
J Med Virol; 2010 Dec; 82(12):2004-12. PubMed ID: 20981786
[TBL] [Abstract][Full Text] [Related]
10. A CCR5
Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
[TBL] [Abstract][Full Text] [Related]
11. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
[TBL] [Abstract][Full Text] [Related]
12. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
[TBL] [Abstract][Full Text] [Related]
13. Chemokine Coreceptor Usage Among HIV-1 Drug-Naive Patients Residing in the Rural Eastern Cape, South Africa.
Digban TO; Iweriebor BC; Nwodo UU; Okoh AI; Obi LC
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):688-696. PubMed ID: 32466656
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.
Singh A; Collman RG
J Virol; 2000 Nov; 74(21):10229-35. PubMed ID: 11024154
[TBL] [Abstract][Full Text] [Related]
16. R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.
Tasca S; Ho SH; Cheng-Mayer C
J Virol; 2008 Jul; 82(14):7089-99. PubMed ID: 18480460
[TBL] [Abstract][Full Text] [Related]
17. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
[TBL] [Abstract][Full Text] [Related]
18. High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.
Mild M; Gray RR; Kvist A; Lemey P; Goodenow MM; Fenyö EM; Albert J; Salemi M; Esbjörnsson J; Medstrand P
Infect Genet Evol; 2013 Oct; 19():369-77. PubMed ID: 23672855
[TBL] [Abstract][Full Text] [Related]
19. Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.
Le AQ; Taylor J; Dong W; McCloskey R; Woods C; Danroth R; Hayashi K; Milloy MJ; Poon AF; Brumme ZL
Sci Rep; 2015 Dec; 5():17607. PubMed ID: 26631642
[TBL] [Abstract][Full Text] [Related]
20. Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.
Lin NH; Becerril C; Giguel F; Novitsky V; Moyo S; Makhema J; Essex M; Lockman S; Kuritzkes DR; Sagar M
Virology; 2012 Nov; 433(2):296-307. PubMed ID: 22954962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]